JF

Jeffrey Finer

Septerna and Third Rock Ventures

South San Francisco, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Oncology
Assay Development
Lifesciences
Molecular Biology
Drug Discovery
Biomarker Discovery
Life Sciences
Pharmaceutical Industry
Biotechnology
Validation
Technology Transfer
Drug Development
Biochemistry
Cell Culture
Pharmacology
HPLC
Clinical Development
Cancer
CRO
Biopharmaceuticals

Education

Investments

Septerna

Series A

Total Funding: $250M

Work Experience

Septerna

2019

  • CEO and Co-Founder

    2019

Third Rock Ventures

2016

  • Venture Partner

    2016

Maze Therapeutics

2016

  • Board Observer

    2019

  • Interim Chief Technology Officer

    2016 - 2019

Strateos

2019 - 2024

  • Board Member

    2019 - 2024

  • Board Chairman

    2019 - 2022

Ambys Medicines

2017 - 2022

  • Board Observer

    2019 - 2022

  • Interim Chief Technology Officer

    2017 - 2019

Transcriptic

2018 - 2019

  • Board Member

    2018 - 2019

Theravance Biopharma, Inc.

2011 - 2016

  • Vice President, Research Technology

    2014 - 2016

  • Vice President, Molecular & Cellular Biology

    2011 - 2014

Five Prime Therapeutics

2007 - 2011

  • Vice President, Discovery

    2007 - 2011

Cytokinetics

1998 - 2007

  • Director, Drug Discovery Technologies

    1998 - 2007

Massachusetts Eye and Ear

1996 - 1998

  • Resident Physician & Surgeon, Ophthalmology

    1996 - 1998